Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.58USD
18 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.58
Open
$3.56
Day's High
$3.64
Day's Low
$3.50
Volume
88,335
Avg. Vol
46,498
52-wk High
$6.88
52-wk Low
$2.33

Hanna, Bruce 

Dr. Bruce A. Hanna, Ph.D., is Independent Director of the Company. He is currently a Clinical Professor of Pathology and Clinical Professor of Microbiology at the New York University School of Medicine, Adjunct Professor of Science at New York University College of Dentistry, and Adjunct Professor of Biology, Long Island University. From 2006 to 2015, he served on the ASM International Committee and WHO Global Committee, from 2000-2012 he served as the Editor of the Clinical Microbiology Review, and 2008-2010 was Interim Director of Pathology, Bellevue Hospital Center. Dr. Hanna earned a Bachelor of Science in Biology from Saint Bonaventure University, a Masters in Science in Microbiology from Northeastern University, and a Ph.D. in Microbiology from Saint John’s University. Dr. Hanna’s post-doctorate work in Clinical Microbiology was at Mt. Sinai Hospital.

Basic Compensation

Total Annual Compensation, USD 62,500
Restricted Stock Award, USD 100,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 162,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018